To the Future: The Role of Exosome-Derived microRNAs as Markers, Mediators, and Therapies for Endothelial Dysfunction in Type 2 Diabetes Mellitus
The prevalence of diabetes mellitus (DM) is increasing at a staggering rate around the world. In the United States, more than 30.3 million Americans have DM. Type 2 diabetes mellitus (T2DM) accounts for 91.2% of diabetic cases and disproportionately affects African Americans and Hispanics. T2DM is a...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2022/5126968 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850166128632922112 |
|---|---|
| author | Maurice B. Fluitt Neal Mohit Kanwal K. Gambhir Gail Nunlee-Bland |
| author_facet | Maurice B. Fluitt Neal Mohit Kanwal K. Gambhir Gail Nunlee-Bland |
| author_sort | Maurice B. Fluitt |
| collection | DOAJ |
| description | The prevalence of diabetes mellitus (DM) is increasing at a staggering rate around the world. In the United States, more than 30.3 million Americans have DM. Type 2 diabetes mellitus (T2DM) accounts for 91.2% of diabetic cases and disproportionately affects African Americans and Hispanics. T2DM is a major risk factor for cardiovascular disease (CVD) and is the leading cause of morbidity and mortality among diabetic patients. While significant advances in T2DM treatment have been made, intensive glucose control has failed to reduce the development of macro and microvascular related deaths in this group. This highlights the need to further elucidate the underlying molecular mechanisms contributing to CVD in the setting of T2DM. Endothelial dysfunction (ED) plays an important role in the development of diabetes-induced vascular complications, including CVD and diabetic nephropathy (DN). Thus, the endothelium provides a lucrative means to investigate the molecular events involved in the development of vascular complications associated with T2DM. microRNAs (miRNA) participate in numerous cellular responses, including mediating messages in vascular homeostasis. Exosomes are small extracellular vesicles (40-160 nanometers) that are abundant in circulation and can deliver various molecules, including miRNAs, from donor to recipient cells to facilitate cell-to-cell communication. Endothelial cells are in constant contact with exosomes (and exosomal content) that can induce a functional response. This review discusses the modulatory role of exosomal miRNAs and proteins in diabetes-induced endothelial dysfunction, highlighting the significance of miRNAs as markers, mediators, and potential therapeutic interventions to ameliorate ED in this patient group. |
| format | Article |
| id | doaj-art-dd103aeba9ef4731a90a24e35491a840 |
| institution | OA Journals |
| issn | 2314-6753 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Diabetes Research |
| spelling | doaj-art-dd103aeba9ef4731a90a24e35491a8402025-08-20T02:21:33ZengWileyJournal of Diabetes Research2314-67532022-01-01202210.1155/2022/5126968To the Future: The Role of Exosome-Derived microRNAs as Markers, Mediators, and Therapies for Endothelial Dysfunction in Type 2 Diabetes MellitusMaurice B. Fluitt0Neal Mohit1Kanwal K. Gambhir2Gail Nunlee-Bland3Division of Endocrinology and MetabolismDivision of Endocrinology and MetabolismDivision of Endocrinology and MetabolismDivision of Endocrinology and MetabolismThe prevalence of diabetes mellitus (DM) is increasing at a staggering rate around the world. In the United States, more than 30.3 million Americans have DM. Type 2 diabetes mellitus (T2DM) accounts for 91.2% of diabetic cases and disproportionately affects African Americans and Hispanics. T2DM is a major risk factor for cardiovascular disease (CVD) and is the leading cause of morbidity and mortality among diabetic patients. While significant advances in T2DM treatment have been made, intensive glucose control has failed to reduce the development of macro and microvascular related deaths in this group. This highlights the need to further elucidate the underlying molecular mechanisms contributing to CVD in the setting of T2DM. Endothelial dysfunction (ED) plays an important role in the development of diabetes-induced vascular complications, including CVD and diabetic nephropathy (DN). Thus, the endothelium provides a lucrative means to investigate the molecular events involved in the development of vascular complications associated with T2DM. microRNAs (miRNA) participate in numerous cellular responses, including mediating messages in vascular homeostasis. Exosomes are small extracellular vesicles (40-160 nanometers) that are abundant in circulation and can deliver various molecules, including miRNAs, from donor to recipient cells to facilitate cell-to-cell communication. Endothelial cells are in constant contact with exosomes (and exosomal content) that can induce a functional response. This review discusses the modulatory role of exosomal miRNAs and proteins in diabetes-induced endothelial dysfunction, highlighting the significance of miRNAs as markers, mediators, and potential therapeutic interventions to ameliorate ED in this patient group.http://dx.doi.org/10.1155/2022/5126968 |
| spellingShingle | Maurice B. Fluitt Neal Mohit Kanwal K. Gambhir Gail Nunlee-Bland To the Future: The Role of Exosome-Derived microRNAs as Markers, Mediators, and Therapies for Endothelial Dysfunction in Type 2 Diabetes Mellitus Journal of Diabetes Research |
| title | To the Future: The Role of Exosome-Derived microRNAs as Markers, Mediators, and Therapies for Endothelial Dysfunction in Type 2 Diabetes Mellitus |
| title_full | To the Future: The Role of Exosome-Derived microRNAs as Markers, Mediators, and Therapies for Endothelial Dysfunction in Type 2 Diabetes Mellitus |
| title_fullStr | To the Future: The Role of Exosome-Derived microRNAs as Markers, Mediators, and Therapies for Endothelial Dysfunction in Type 2 Diabetes Mellitus |
| title_full_unstemmed | To the Future: The Role of Exosome-Derived microRNAs as Markers, Mediators, and Therapies for Endothelial Dysfunction in Type 2 Diabetes Mellitus |
| title_short | To the Future: The Role of Exosome-Derived microRNAs as Markers, Mediators, and Therapies for Endothelial Dysfunction in Type 2 Diabetes Mellitus |
| title_sort | to the future the role of exosome derived micrornas as markers mediators and therapies for endothelial dysfunction in type 2 diabetes mellitus |
| url | http://dx.doi.org/10.1155/2022/5126968 |
| work_keys_str_mv | AT mauricebfluitt tothefuturetheroleofexosomederivedmicrornasasmarkersmediatorsandtherapiesforendothelialdysfunctionintype2diabetesmellitus AT nealmohit tothefuturetheroleofexosomederivedmicrornasasmarkersmediatorsandtherapiesforendothelialdysfunctionintype2diabetesmellitus AT kanwalkgambhir tothefuturetheroleofexosomederivedmicrornasasmarkersmediatorsandtherapiesforendothelialdysfunctionintype2diabetesmellitus AT gailnunleebland tothefuturetheroleofexosomederivedmicrornasasmarkersmediatorsandtherapiesforendothelialdysfunctionintype2diabetesmellitus |